Navigating Civil Standing Requirements for Defense Success — RICO Report Podcast
Supreme Court to Settle Circuit Split Regarding RICO Damages Arising From Personal Injuries — RICO Report Podcast
RICO Vicarious Liability — RICO Report Podcast
RICO Damages — RICO Report Podcast
AGG Talks: Antitrust and White-Collar Crime Roundup - Breaking Down Ongoing Litigation Against Trump and Colorado’s Primary Ballot
RICO Lawsuit Against Shein — RICO Report Podcast
RICO and Foreign Arbitration Enforcement - RICO Report Podcast
State RICO Statutes - RICO Report Podcast
Unlawful Debt Collection Claims - RICO Report Podcast
Mail and Wire Fraud Claims - RICO Report Podcast
Defining the RICO Racketeering Element - RICO Report Podcast
The “Pattern” of Racketeering Activity - Regulatory Oversight Podcast
The "Pattern" of Racketeering Activity - RICO Report Podcast
Understanding the RICO Enterprise Requirement - RICO Report Podcast
The Intersection of RICO, Trade Secrets, and the Defend Trade Secrets Act - RICO Report Podcast
RICO Conduct (18 U.S.C. §§ 1962(a-d)) - RICO Report Podcast
The Justice Insiders: FIFA Corruption Trial – Will the Feds Score Another Goal?
Second Circuit Decision Potentially Broadens RICO Proximate Cause Element - RICO Report Podcast
Introduction to RICO: What You Need to Know - RICO Report Podcast
Anatomy of a Successful Motion to Dismiss in RICO Case
In Westfield National Insurance Co. v. Quest Pharmaceuticals, the Sixth Circuit held that two insurers owed no coverage obligations to Quest Pharmaceuticals in connection with 77 lawsuits filed against it alleging misconduct...more
A Kansas District Court recently reinforced that cases alleging claims outside the Judicial Panel on Multidistrict Litigation (JPML) Transfer Order cannot be employed to broaden the scope of the MDL litigation. In reaching...more
Takeaway: To have standing to assert a civil RICO claim, federal RICO’s proximate cause requirement demands that there be a “direct relation” between the RICO violation and injury. ...more
Opioid manufacturers, distributors, pharmacies and prescribers are facing a deluge of lawsuits that involve criminal and civil claims in both federal and state courts. On May 2, 2019, a federal jury in Boston, Massachusetts,...more
This latest installment of the Health Care Enforcement Quarterly Roundup reflects on trends that persisted in 2018 and those emerging trends that will carry us into 2019 and beyond. Leading off with the US Department of...more
The government’s FCA enforcement efforts have continued to focus on key areas concerning the pharmaceutical and medical device industries. In fact, drug and device manufacturers accounted for nearly half of the enforcement...more
After a conventional presidential campaign, determining the policy priorities and direction of the incoming administration with respect to the Justice Department’s white collar law enforcement responsibilities can be a...more
Alien Tort Statute (ATS)/Torture Victims Protection Act (TVPA)/Anti-Terrorism Act (ATA) - District Court Dismisses ATS Claim Where Alleged Conduct in US Was Not Directly Linked to Injuries Claimed in Other Countries - ...more
Pharmaceutical manufacturers that promote off-label uses for prescription drugs have become litigation targets for third-party payors—especially after Kaiser received a nine-figure RICO award last year against the...more
The fight against sophisticated online schemes to sell counterfeit or otherwise illegal goods is being waged by increasingly focused efforts to identify responsible parties that may be sued in U.S. courts, and whose assets...more
In Harden Manufacturing Co. v. Pfizer, Inc., 712 F.3d 60 (1st Cir. 2013), one of three cases addressing Pfizer’s off-label marketing of the anticonvulsant drug, Neurontin, the First Circuit vacated the district court’s denial...more